Gastroenteroviruses infection in Taiwan

Open Infectious Diseases Journal

Volumn 3, Issue 1, 2009, Pages 37-43

  Lu, Tsong Ming ^a,b   Tsai, Hsiu Ting ^a   Cheng, Yu Wen ^c   Chin, Lengsu William ^a,d   Yang, Chi Chiang ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c Lee General Hospital   (Taiwan)

^d Department of Physical Therapy and Rehabilitation Da Chien General Hospital   (Taiwan)

Author keywords

Gastroenteritis; Gastroenterovirus; Taiwan

Indexed keywords

EID: 84870782553     PISSN: None     EISSN: 18742793     Source Type: Journal    
DOI: 10.2174/1874279300903010037     Document Type: Review

References (93)

1. Chen KT, Fan SF, Tang RB, et al. Hospital-based study of the economic burden associated with rotavirus diarrhea in Taiwan. Vaccine 2007; 25(21): 4266-4272.
2. Yang CC, Ku CS, Lin SJ, Marguerite B, Chen CK. Diagnosis of gastroenteric viruses in fecal specimens from pediatric patients in Taiwan. J Biomed Lab Sci 2001; 13: 63-71.
3. Chen SM, Ni YH, Chen HL, Chang MH. Microbial etiology of acute gastroenteritis in hospitalized children in Taiwan. J Formos Med Assoc 2006; 105(12): 964-970.
4. Sung YL, Huang YF, Huang CF, et al. Emergence of G9 serotype rotavirus as a major cause of infectious gastroenteritis in southern Taiwan. J Microbiol Immunol Infect 2004; 37(6): 322-326.
5. Lawton JA, Zeng CQ, Mukherjee SK, Cohen J, Estes MK, Prasad BV. Three-dimensional structural analysis of recombinant rotavi-rus-like particles with intact and amino-terminal-deleted VP2: implications for the architecture of the VP2 capsid layer. J Virol 1997; 71(10): 7353-7360.
6. Hoshino Y, Jones RW, Chanock RM, Kapikian AZ. Generation and characterization of six single VP4 gene substitution reassortant rota-virus vaccine candidates: each bears a single human rotavirus VP4 gene encoding P serotype 1A[8] or 1B[4] and the remaining 10 genes of rhesus monkey rotavirus MMU18006 or bovine rotavirus UK. Vaccine 2002; 20(29-30): 3576-3584.
7. Kapikian AZ, Hoshino Y, Chanock RM, Perez-Schael I. Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. J Infect Dis 1996; 174(Suppl 1): S65-S72.
8. Hoshino Y, Kapikian AZ. Rotavirus antigens. Curr Top Microbiol Immunol 1994; 185: 179-227.
9. Lai HC, Lin SJ, Lin HR, Ku CS, Wang L, Yang CC. Phylogenetic analyses of human rotavirus in central Taiwan in 1996, 2001 and 2002. J Clin Virol 2005; 32(3): 199-217.
10. Martella V, Ciarlet M, Bányai K, et al. Identification of a novel VP4 genotype carried by a serotype G5 porcine rotavirus strain. Virology 2006; 346(2): 301-311.
11. Fruhwirth M, Karmaus W, Moll-Schuler I, Brosl S, Mutz I. A prospective evaluation of community acquired gastroenteritis in paediatric practices: impact and disease burden of rotavirus infection. Arch Dis Child 2001; 84(5): 393-397.
12. Lin HC, Kao CL, Lu CY, et al. Enteric adenovirus infection in children in Taipei. J Microbiol Immunol Infect 2000; 33(3): 176-180.
13. Zheng BJ, Lo SK, Tam JS, Lo M, Yeung CY, Ng MH. Prospective study of community-acquired rotavirus infection. J Clin Microbiol 1989; 27(9): 2083-2090.
14. Lin AY, Lin CY, Chen CT, Chen WL. Host defense against Salmonella and rotaviral gastroenteritis: a serial study of transcrip-tional factors and cytokines. J Microbiol Immunol Infect 2008; 41(3): 265-271.
15. Chiu TF, Lee CN, Lee PI, et al. Rotavirus gastroenteritis in children: 5-year experience in a medical center. J Microbiol Immunol Infect 2000; 33(3): 181-186.
16. Lin SC, Hsu HY, Wang PJ, et al. Rotavirus gastroenteritis associated with afebrile seizure in childhood. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1996; 37(3): 204-207.
17. th ed. Philadelphia: Lippincott-Raven 2001; 2: pp. 1787-1833.
18. Chen SY, Chang YC, Lee YS, et al. Molecular epidemiology and clinical manifestations of viral gastroenteritis in hospitalized pedi-atric patients in Northern Taiwan. J Clin Microbiol 2007; 45(6): 2054-2057.
19. Chen KT, Chen PY, Tang RB, et al. Sentinel hospital surveillance for rotavirus diarrhea in Taiwan, 2001-2003. J Infect Dis 2005; 192 (Suppl 1): S44-S48.
20. Liu LJ, Yang YJ, Kuo PH, Wang SM, Liu CC. Diagnostic value of bacterial stool cultures and viral antigen tests based on clinical manifestations of acute gastroenteritis in pediatric patients. Eur J Clin Microbiol Infect Dis 2005; 24(8): 559-561.
21. Zao CL, Yu WN, Kao CL, Taniguchi K, Lee CY, Lee CN. Sequence analysis of VP1 and VP7 genes suggests occurrence of a reassortant of G2 rotavirus responsible for an epidemic of gastroenteritis. J Gen Virol 1999; 80 (Pt 6): 1407-1415.
22. Echeverria P, Ho MT, Blacklow NR, et al. Relative importance of viruses and bacteria in the etiology of pediatric diarrhea in Taiwan. J Infect Dis 1977; 136(3): 383-390.
23. Aranda-Michel J, Giannella RA. Acute diarrhea: a practical review. Am J Med 1999; 106(6): 670-676.
24. Arista S, Vizzi E, Migliore MC, Di Rosa E, Cascio A. High incidence of G9P181 rotavirus infections in Italian children during the winter season 1999-2000. Eur J Epidemiol 2003; 18(7): 711-714.
25. Cunliffe NA, Dove W, Bunn JE, et al. Expanding global distribution of rotavirus serotype G9: detection in Libya, Kenya, and Cuba. Emerg Infect Dis 2001; 7(5): 890-892.
26. Zhou Y, Supawadee J, Khamwan C, et al. Characterization of human rotavirus serotype G9 isolated in Japan and Thailand from 1995 to 1997. J Med Virol 2001; 65(3): 619-628.
27. Araujo IT, Ferreira MS, Fialho AM, et al. Rotavirus genotypes P[4]G9, P[6]G9, and P[8]G9 in hospitalized children with acute gastroenteritis in Rio de Janeiro, Brazil. J Clin Microbiol 2001; 39(5): 1999-2001.
28. Bok K, Palacios G, Sijvarger K, Matson D, Gomez J. Emergence of G9 P[6] human rotaviruses in Argentina: phylogenetic relationships among G9 strains. J Clin Microbiol 2001; 39(11): 4020-4025.
29. Bon F, Fromantin C, Aho S, Pothier P, Kohli E. G and P genotyp-ing of rotavirus strains circulating in france over a three-year period: detection of G9 and P[6] strains at low frequencies. The AZAY Group. J Clin Microbiol 2000; 38(4): 1681-1683.
30. Iturriza-Gomara M, Cubitt D, Steele D, et al. Characterisation of rotavirus G9 strains isolated in the UK between 1995 and 1998. J Med Virol 2000; 61(4): 510-517.
31. Palombo EA, Masendycz PJ, Bugg HC, Bogdanovic-Sakran N, Barnes GL, Bishop RF. Emergence of serotype G9 human rotavi-ruses in Australia. J Clin Microbiol 2000; 38(3): 1305-1306.
32. Kirkwood CD, Gentsch JR, Hoshino Y, Clark HF, Glass RI. Genetic and antigenic characterization of a serotype P[6]G9 human rotavirus strain isolated in the United States. Virology 1999; 256(1): 45-53.
33. Unicomb LE, Podder G, Gentsch JR, et al. Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995. J Clin Microbiol 1999; 37(6): 1885-1891.
34. Ramachandran M, Das BK, Vij A, et al. Unusual diversity of human rotavirus G and P genotypes in India. J Clin Microbiol 1996; 34(2): 436-439.
35. Ramachandran M, Kirkwood CD, Unicomb L, et al. Molecular characterization of serotype G9 rotavirus strains from a global collection. Virology 2000; 278(2): 436-444.
36. Lin YP, Chang SY, Kao CL, et al. Molecular epidemiology of G9 rotaviruses in Taiwan between 2000 and 2002. J Clin Microbiol 2006; 44(10): 3686-3694.
37. Masendycz PJ, Palombo EA. Genetic relatedness of VP1 genes of Australian and Taiwanese rotavirus isolates. FEMS Microbiol Lett 2001; 198(2): 147-150.
38. Palombo EA, Bugg HC, Masendycz PJ, Coulson BS, Barnes GL, Bishop RF. Multiple-gene rotavirus reassortants responsible for an outbreak of gastroenteritis in central and northern Australia. J Gen Virol 1996; 77 (Pt 6): 1223-1227.
39. Uhnoo I, Wadell G, Svensson L, Johansson ME. Importance of enteric adenoviruses 40 and 41 in acute gastroenteritis in infants and young children. J Clin Microbiol 1984; 20(3): 365-372.
40. Kidd AH, Rosenblatt A, Besselaar TG, et al. Characterization of rotaviruses and subgroup F adenoviruses from acute summer gastroenteritis in South Africa. J Med Virol 1986; 18(2): 159-168.
41. Brandt CD, Kim HW, Rodriguez WJ, et al. Adenoviruses and pediatric gastroenteritis. J Infect Dis 1985; 151(3): 437-443.
42. Kaplan JE, Schonberger LB, Varano G, Jackman N, Bied J, Gary GW. An outbreak of acute nonbacterial gastroenteritis in a nursing home: demonstration of person-to-person transmission by temporal clustering of cases. Am J Epidemiol 1982; 116(6): 940-948.
43. Ramirez S, Giammanco GM, De Grazia S, Colomba C, Martella V, Arista S. Genotyping of GII.4 and GIIb norovirus RT-PCR ampli-cons by RFLP analysis. J Virol Methods 2008; 147(2): 250-256.
44. Kageyama T, Shinohara M, Uchida K, et al. Coexistence of multiple genotypes, including newly identified genotypes, in outbreaks of gastroenteritis due to Norovirus in Japan. J Clin Microbiol 2004; 42(7): 2988-2995.
45. Tu ET, Bull RA, Greening GE, et al. Epidemics of gastroenteritis during 2006 were associated with the spread of norovirus GII.4 variants 2006a and 2006b. Clin Infect Dis 2008; 46(3): 413-420.
46. Thornton AC, Jennings-Conklin KS, McCormick MI. Noroviruses: agents in outbreaks of acute gastroenteritis. Disaster Manag Response 2004; 2(1): 4-9.
47. Wu FT, Oka T, Katayama K, et al. Genetic diversity of noroviruses in Taiwan between November 2004 and March 2005. Arch Virol 2006; 151(7): 1319-1327.
48. Wu FT, Oka T, Takeda N, et al. Acute gastroenteritis caused by GI/2 sapovirus, Taiwan, 2007. Emerg Infect Dis 2008; 14(7): 1169-1171.
49. Madeley CR, Cosgrove BP. Letter: 28 nm particles in faeces in infantile gastroenteritis. Lancet 1975; 2(7932): 451-452.
50. Cook N, Myint S. Astroviruses. J Med Microbiol 1995; 42(1): 1-2.
51. Lin HC, Kao CL, Chang LY, et al. Astrovirus gastroenteritis in children in Taipei. J Formos Med Assoc 2008; 107(4): 295-303.
52. Melnick JL, Tagaya I, von Magnus H. Enteroviruses 69, 70, and 71. Intervirology 1974; 4(6): 369-370.
53. Hsiung GD, Wang JR. Enterovirus infections with special reference to enterovirus 71. J Microbiol Immunol Infect 2000; 33(1): 1-8.
54. Ho M, Chen ER, Hsu KH, et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 1999; 341(13): 929-935.
55. Gau SS, Chang LY, Huang LM, Fan TY, Wu YY, Lin TY. Atten-tion-deficit/hyperactivity-related symptoms among children with enterovirus 71 infection of the central nervous system. Pediatrics 2008; 122(2): e452-e458.
56. Chang LY, Lin TY, Hsu KH, et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 1999; 354(9191): 1682-1686.
57. Johnsen IB, Nguyen TT, Ringdal M, et al. Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling. EMBO J 2006; 25(14): 3335-3346.
58. McCartney SA, Thackray LB, Gitlin L, Gilfillan S, Virgin HW, Colonna M. MDA-5 recognition of a murine norovirus. PLoS Pathog 2008; 4(7): e1000108.
59. Mesa MC, Rodriguez LS, Franco MA, Angel J. Interaction of rota-virus with human peripheral blood mononuclear cells: plasmacy-toid dendritic cells play a role in stimulating memory rotavirus specific T cells in vitro. Virology 2007; 366(1): 174-184.
60. Hanauer SB. Inflammatory bowel disease: epidemiology, patho-genesis, and therapeutic opportunities. Inflamm Bowel Dis 2006; 12(Suppl 1): S3-S9.
61. Wahid R, Cannon MJ, Chow M. Virus-specific CD4+ and CD8+ cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polio. J Virol 2005; 79(10): 5988-5995.
62. Michalak TI, Hodgson PD, Churchill ND. Posttranscriptional inhibition of class I major histocompatibility complex presentation on hepatocytes and lymphoid cells in chronic woodchuck hepatitis virus infection. J Virol 2000; 74(10): 4483-4494.
63. Guidotti LG, Chisari FV. To kill or to cure: options in host defense against viral infection. Curr Opin Immunol 1996; 8(4): 478-483.
64. Chen KS, Wang PH, Yang SF, et al. Significant elevation of a Th2 cytokine, interleukin-10, in pelvic inflammatory disease. Clin Chem Lab Med 2008; 46(11): 1609-1616.
65. Wood DJ, David TJ, Chrystie IL, Totterdell B. Chronic enteric virus infection in two T-cell immunodeficient children. J Med Virol 1988; 24(4): 435-444.
66. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17(3): 138-146.
67. Billiau A. Interferon-gamma: biology and role in pathogenesis. Adv Immunol 1996; 62: 61-130.
68. Seder RA, Paul WE. Acquisition of lymphokine-producing pheno-type by CD4+ T cells. Annu Rev Immunol 1994; 12: 635-673.
69. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136(7): 2348-2357.
70. Paludan SR. Interleukin-4 and interferon-gamma: the quintessence of a mutual antagonistic relationship. Scand J Immunol 1998; 48(5): 459-468.
71. Cavaillon JM, Fitting C, Haeffner-Cavaillon N, Kirsch SJ, Warren HS. Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide. Infect Immun 1990; 58(7): 2375-23382.
72. Franco MA, Greenberg HB. Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J Virol 1995; 69(12): 7800-7806.
73. Guo L, Wang J, Zhou H, et al. Intranasal administration of a re-combinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice. Vaccine 2008; 26(4): 460-468.
74. Weinzierl AO, Rudolf D, Maurer D, et al. Identification of HLA-A*01- and HLA-A*02-restricted CD8+ T-cell epitopes shared among group B enteroviruses. J Gen Virol 2008; 89(Pt 9): 2090-2097.
75. Fischler B, Nystrom J, Bjornsdottir T, Lindh G, Hultgren C. Virus-specific T cell immune response in children and adolescents with chronic hepatitis B virus infection. J Pediatr Gastroenterol Nutr 2007; 45(1): 75-83.
76. Freigang S, Egger D, Bienz K, Hengartner H, Zinkernagel RM. Endogenous neosynthesis vs cross-presentation of viral antigens for cytotoxic T cell priming. Proc Natl Acad Sci USA 2003; 100(23): 13477-13482.
77. Buesa J, Raga JV, Colomina J, de Souza CO, Munoz C, Gil MT. Rotavirus-specific cytotoxic T lymphocytes recognize overlapping epitopes in the amino-terminal region of the VP7 glycoprotein. Virology 1999; 257(2): 424-437.
78. Jaimes MC, Feng N, Greenberg HB. Characterization of homologous and heterologous rotavirus-specific T-cell responses in infant and adult mice. J Virol 2005; 79(8): 4568-4579.
79. Kobayashi S, Kobayashi M, Araki K, Shinozaki T, Yanagawa Y. Antibody prevalence against astrovirus according to age groups. Kansenshogaku Zasshi 1999; 73(6): 578-583.
80. Schaffer FM, Newton JA. Intravenous gamma globulin administration to common variable immunodeficient women during pregnancy: case report and review of the literature. J Perinatol 1994; 14(2): 114-117.
81. van Loon AM, Heessen FW, van der Logt JT. Antibody isotype response after human cytomegalovirus infection. J Virol Methods 1987; 15(2): 101-107.
82. Carricart SE, Bustos D, Biganzoli P, Nates SE, Pavan JV. Isotype immune response of IgG antibodies at the persistence and reactivation stages of human herpes virus 6 infection. J Clin Virol 2004; 31(4): 266-269.
83. Jenison S, Yamada T, Morris C, et al. Characterization of human antibody responses to four corners hantavirus infections among patients with hantavirus pulmonary syndrome. J Virol 1994; 68(5): 3000-3006.
84. Lundkvist A, Bjorsten S, Niklasson B. Immunoglobulin G subclass responses against the structural components of Puumala virus. J Clin Microbiol 1993; 31(2): 368-372.
85. Khalife J, Guy B, Capron M, et al. Isotypic restriction of the antibody response to human immunodeficiency virus. AIDS Res Hum Retroviruses 1988; 4(1): 3-9.
86. Tsai TH, Huang CF, Wei JC, et al. Study of IgG subclass profiles of anti-HBs in populations with different HBV infection status. Viral Immunol 2006; 19(2): 277-284.
87. Yang YY, Huang CF, Wei JC, et al. The study of IgG subclass profiles of anti-hbc in populations with different status of HBV infection. Cell Mol Immunol 2005; 2(5): 393-398.
88. Wang L, Lin SJ, Tsai JH, Tsai CH, Tsai CC, Yang CC. Anti-hepatitis B surface antigen IgG1 subclass is predominant in individuals who have recovered from hepatitis B virus infection, chronic carriers, and vaccinees. Med Microbiol Immunol 2005; 194(1-2): 33-38.
89. Yang CC, Lin CC, Wang L, Ku CS, Chen CK. Anti-HBc IgG subclasses in different populations by comparing a variety of ELISA plates. J Immunoassay Immunochem 2001; 22(1): 33-45.
90. Ahmad NM, Ahmad KM, Younus F. Severe adenovirus pneumonia (AVP) following infliximab infusion for the treatment of Crohn's disease. J Infect 2007; 54(1): e29-e32.
91. Franco MA, Greenberg HB. Immunity to rotavirus in T cell deficient mice. Virology 1997; 238(2): 169-179.
92. Molberg O, Nilsen EM, Sollid LM, et al. CD4+ T cells with specific reactivity against astrovirus isolated from normal human small intestine. Gastroenterology 1998; 114(1): 115-122.
93. Schaffer FM, Monteiro RC, Volanakis JE, Cooper MD. IgA deficiency. Immunodefic Rev 1991; 3(1): 15-44.